Prenetics Global Ltd (NASDAQ:PRE) — Market Cap & Net Worth
Market Cap & Net Worth: Prenetics Global Ltd (PRE)
Prenetics Global Ltd (NASDAQ:PRE) has a market capitalization of $312.73 Million ($312.73 Million) as of June 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #14730 globally and #3431 in its home market, demonstrating a 2.55% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Prenetics Global Ltd's stock price $20.51 by its total outstanding shares 15247465 (15.25 Million). Review how much debt does Prenetics Global Ltd carry to assess the company's total debt and financial obligations.
Prenetics Global Ltd Market Cap History: 2021 to 2026
Prenetics Global Ltd's market capitalization history from 2021 to 2026. Data shows change from $1.76 Billion to $312.73 Million (-29.76% CAGR).
Index Memberships
Prenetics Global Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.43 Trillion | 0.01% | #393 of 976 |
|
NASDAQ Composite
IXIC
|
$41.27 Trillion | 0.00% | #1426 of 3165 |
Weight: Prenetics Global Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Prenetics Global Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Prenetics Global Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.89x
Prenetics Global Ltd's market cap is 2.89 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.76 Billion | $12.53 Million | -$174.01 Million | 140.05x | N/A |
| 2022 | $457.42 Million | $13.16 Million | -$190.45 Million | 34.75x | N/A |
| 2023 | $90.11 Million | $21.74 Million | -$62.72 Million | 4.14x | N/A |
| 2024 | $88.44 Million | $30.62 Million | -$46.30 Million | 2.89x | N/A |
Competitor Companies of PRE by Market Capitalization
Companies near Prenetics Global Ltd in the global market cap rankings as of June 17, 2026.
Key companies related to Prenetics Global Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #127 globally with a market cap of $177.57 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #182 globally with a market cap of $128.10 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #626 globally with a market cap of $44.18 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #663 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #127 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.57 Billion | $472.63 |
| #182 | Danaher Corporation | NYSE:DHR | $128.10 Billion | $181.35 |
| #626 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.18 Billion | $573.00 |
| #663 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Prenetics Global Ltd Historical Marketcap From 2021 to 2026
Between 2021 and today, Prenetics Global Ltd's market cap moved from $1.76 Billion to $ 312.73 Million, with a yearly change of -29.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $312.73 Million | +30.22% |
| 2025 | $240.15 Million | +171.55% |
| 2024 | $88.44 Million | -1.86% |
| 2023 | $90.11 Million | -80.30% |
| 2022 | $457.42 Million | -73.94% |
| 2021 | $1.76 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Prenetics Global Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $312.73 Million USD |
| MoneyControl | $312.73 Million USD |
| MarketWatch | $312.73 Million USD |
| marketcap.company | $312.73 Million USD |
| Reuters | $312.73 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Prenetics Global Ltd
Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing… Read more